The earnings call reflected a positive outlook with strong revenue growth, increased EBITDA, and improved revenue guidance. However, challenges such as decreased backlog, lower win rates, and higher reimbursable costs were noted. The sustainability of growth into 2026 remains uncertain.

Company Guidance -

Q3 2025

During Medpace's second-quarter 2025 earnings call, the company raised its revenue guidance by $280 million at the midpoint, reflecting a strong performance driven by several factors including improved funding, fewer cancellations, and a shift toward faster-burning therapeutic areas. The revenue for Q2 2025 was reported at $603.3 million, a 14.2% year-over-year increase, while net new business awards increased by 12.6% to $620.5 million, resulting in a book-to-bill ratio of 1.03x. The company anticipates a potential return to a book-to-bill ratio above 1.15x in Q3 2025. EBITDA for Q2 was $130.5 million, marking a 16.2% increase compared to the same quarter last year, with a margin of 21.6%. The guidance for full-year 2025 projects total revenue between $2.42 billion and $2.52 billion, representing growth of 14.7% to 19.5% over 2024, with an expected EBITDA range of $515 million to $545 million. The company also noted a significant increase in reimbursable costs and a forecasted net income range of $405 million to $428 million for 2025.

Strong Revenue Growth

Revenue for Q2 2025 was $603.3 million, a year-over-year increase of 14.2%. Revenue for the six months ended June 30, 2025, was $1.16 billion, up 11.8%.

Increased EBITDA

EBITDA for Q2 2025 was $130.5 million, a 16.2% increase from $112.3 million in Q2 2024. On a constant currency basis, EBITDA increased 18.5%.

Improved Revenue Guidance

Revenue guidance for the full year 2025 increased by $280 million at the midpoint, with total revenue expected between $2.42 billion and $2.52 billion, representing growth of 14.7% to 19.5% over 2024.

Stable Funding Environment

The funding environment showed stability and improvement, with fewer cancellations and better-than-anticipated funding for ongoing studies.

Cash Flow and Share Repurchase

Generated $148.5 million in cash flow from operating activities and repurchased 1.75 million shares for $518.5 million during Q2 2025.

Medpace Holdings (MEDP) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

MEDP Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 27, 2025	2025 (Q3)	3.52 / -	3.01	―	―	―
Jul 21, 2025	2025 (Q2)	2.98 / 3.10	2.75	12.73% (+0.35)
Apr 21, 2025	2025 (Q1)	3.06 / 3.67	3.2	14.69% (+0.47)
Feb 10, 2025	2024 (Q4)	2.94 / 3.67	2.46	49.19% (+1.21)
Oct 21, 2024	2024 (Q3)	2.77 / 3.01	2.22	35.59% (+0.79)
Jul 22, 2024	2024 (Q2)	2.54 / 2.75	1.93	42.49% (+0.82)
Apr 22, 2024	2024 (Q1)	2.47 / 3.20	2.27	40.97% (+0.93)
Feb 12, 2024	2023 (Q4)	2.22 / 2.46	2.12	16.04% (+0.34)
Oct 23, 2023	2023 (Q3)	2.05 / 2.22	2.05	8.29% (+0.17)
Jul 24, 2023	2023 (Q2)	1.91 / 1.93	1.46	32.19% (+0.47)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

MEDP Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 21, 2025	$308.88	$477.73	+54.67%
Apr 21, 2025	$288.99	$282.28	-2.32%
Feb 10, 2025	$354.51	$327.86	-7.52%
Oct 21, 2024	$352.92	$326.54	-7.47%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Medpace Holdings Inc (MEDP) report earnings?

Medpace Holdings Inc (MEDP) is schdueled to report earning on Oct 27, 2025, After Close (Confirmed).

What is Medpace Holdings Inc (MEDP) earnings time?

Medpace Holdings Inc (MEDP) earnings time is at Oct 27, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is MEDP EPS forecast?

MEDP EPS forecast for the fiscal quarter 2025 (Q3) is 3.53.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing